Evidence map›Paper›PMID 40376359›Full record

ArticleCureus2025

Beyond Hypertension: Hypoglycemia as an Atypical Presentation of Pheochromocytoma in Neurofibromatosis Type 1.

Zeinab Alnahas, Anas Kartoumah, Talal Alomar, Kareem Suleiman, Mohamad Horani

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zeinab AlnahasInternal Medicine, Cairo University, Cairo, EGY.
Anas KartoumahBiomedical Sciences, University of South Florida, Tampa, USA.
Talal AlomarInternal Medicine, Creighton University School of Medicine, Phoenix, USA.
Kareem SuleimanBiology, University of South Florida, Tampa, USA.
Mohamad HoraniInternal Medicine, Chandler Regional Medical Center, Chandler, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pheochromocytoma is a rare adrenal tumor characterized by catecholamine hypersecretion. It can occur sporadically or as part of hereditary disorders, such as multiple endocrine neoplasia type 2 (MEN2) and, less commonly, neurofibromatosis type 1 (NF1). Pheochromocytoma can cause metabolic disturbances, including impaired glucose tolerance and hyperglycemia. However, hypoglycemia is typically a postoperative complication rather than an initial presentation. We reported an unusual presentation of pheochromocytoma with persistent hypoglycemia in a patient with NF1. A 27-year-old normotensive woman with a past medical history of NF1 experienced a sudden episode of dizziness and presyncope while she was driving, causing a motor vehicle accident. She was found with persistent hypoglycemia, and her imaging revealed a right adrenal mass. The diagnosis of pheochromocytoma was confirmed through biochemical testing, which revealed significantly elevated serum metanephrines and normetanephrine levels. Our case shows that hereditary pheochromocytoma associated with NF1 can present with persistent hypoglycemia.

Indexed as

adrenal tumorhypoglycemiametabolic dysfunctionneurofibromatosis type 1pheochromocytoma

Identifiers

PMID40376359
PMCPMC12079148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.